Clinical Research Reviews

Three clinical trials of Neuragen® have been completed to date with 160 patients.

Effective for >80% of Sufferers

The graphs below depict a double blind placebo controlled trial by independent researchers at Louisiana State University. 60 subjects experiencing all-cause neuropathic foot pain (top) and a sub group of diabetic neuropathy (bottom) were treated with Neuragen. In both cases greater than 80% of patients received significant relief.

Effective for up to 8 Hours

40 subjects with all-cause neuropathic pain in the feet were treated in a LSU double blind placebo controlled trial. The graph below represents the average pain level for all participants before treatment (time=0) and for up to 9 hours after treatment with either Neuragen (blue drops) or placebo (grey triangles). Pain relief with Neuragen was statistically significant over placebo and for up to 8 hours in duration.

Highly Effective on 63% of Sufferers

Another commonly accepted way to analyze data from pain trials is to compare the number of patients who received at least a 50% reduction in pain level vs. placebo. As shown below, 63% of subjects receiving Neuragen benefited from a 50% or greater reduction in pain, vs. only 15% in the placebo group.

Download a PDF of Clinical Research Reviews Three clinical trials of Neuragen have been completed to date with 160 patients. View the PDF to see the results of these clinical trials. Download Clinical Research Reviews (PDF)